An Italian multicenter, randomized, single blind study of the sirolimus eluting stent in the treatment of diabetic patients with de novo coronary artery lesions

Trial Profile

An Italian multicenter, randomized, single blind study of the sirolimus eluting stent in the treatment of diabetic patients with de novo coronary artery lesions

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2010

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Angina pectoris; Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
  • Focus Therapeutic Use
  • Acronyms DESSERT
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 09 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.
    • 24 Feb 2009 Planned end date changed from 1 Apr 2011 to 1 Apr 2009, according to clinicaltrials.gov.
    • 11 Jun 2008 Results have been published in the American Journal of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top